Genetic and clinical basis for two distinct subtypes of primary Sjögren’s syndrome

OBJECTIVES: Clinical presentation of primary Sjögren’s syndrome (pSS) varies considerably. A shortage of evidence-based objective markers hinders efficient drug development and most clinical trials have failed to reach primary endpoints. METHODS: We performed a multicentre study to identify patient...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Rheumatology (Oxford)
Autores principales: Thorlacius, Guðný Ella, Hultin-Rosenberg, Lina, Sandling, Johanna K, Bianchi, Matteo, Imgenberg-Kreuz, Juliana, Pucholt, Pascal, Theander, Elke, Kvarnström, Marika, Forsblad-d’Elia, Helena, Bucher, Sara Magnusson, Norheim, Katrine B, Johnsen, Svein Joar Auglænd, Hammenfors, Daniel, Skarstein, Kathrine, Jonsson, Malin V, Baecklund, Eva, Aqrawi, Lara A, Jensen, Janicke Liaaen, Palm, Øyvind, Morris, Andrew P, Meadows, Jennifer R S, Rantapää-Dahlqvist, Solbritt, Mandl, Thomas, Eriksson, Per, Lind, Lars, Omdal, Roald, Jonsson, Roland, Lindblad-Toh, Kerstin, Rönnblom, Lars, Wahren-Herlenius, Marie, Nordmark, Gunnel
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2020
Materias:
Clinical Science
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7850528/
https://ncbi.nlm.nih.gov/pubmed/32889544
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/keaa367
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares